Net profit of Alembic Pharmaceuticals declined 23.29% to Rs 138.42 crore in the quarter ended December 2024 as against Rs 180.45 crore during the previous quarter ended December 2023. Sales rose 3.81% to Rs 1692.74 crore in the quarter ended December 2024 as against Rs 1630.57 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 1692.74 | 1630.57 | 4 |
| OPM % | 15.37 | 16.33 | - |
| PBDT | 247.82 | 254.04 | -2 |
| PBT | 177.78 | 184.59 | -4 |
| NP | 138.42 | 180.45 | -23 |
Powered by Capital Market - Live News